Hospital
Grand Island Regional Medical Center
Grand Island Regional Medical Center was paid $1.62M by Medicaid between Nov 2020 and Dec 2024, across 66 billing codes. Its largest line is 99283, emergency room visit (moderate) — 43% of everything it billed.
33Billing provider infoGRAND ISLAND REGIONAL MEDICAL CENTER
GRAND ISLAND, NE 68803
GRAND ISLAND, NE 68803
33aNPI1558910604assigned 09/10/2019
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.62M
24GClaims27,226
24DCodes billed66
24AFirst – last monthNov 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Nebraska
Rank by total paid#5 of 8
Median peer was paid$1.62M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 81 | $8K | |
| 2021 | 7,641 | $420K | |
| 2022 | 10,308 | $597K | |
| 2023 | 5,975 | $293K | |
| 2024incomplete | 3,221 | $301K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 43% | 3,850 | 3,585 | $701K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 2,519 | 2,349 | $437K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11% | 1,155 | 1,082 | $170K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.7% | 297 | 234 | $108K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.2% | 257 | 153 | $52K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.7% | 157 | 148 | $44K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.4% | 191 | 180 | $23K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 707 | 690 | $19K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 136 | 133 | $18K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 33 | 31 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 37 | 37 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 31 | 28 | $5K |
54 more codes
| 80053 | Comprehensive metabolic panel | <1% | 2,330 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,179 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $3K |
| G0378 | Hospital observation service, per hour | <1% | 52 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $3K |
| G0238 | Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) | <1% | 18 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,241 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 538 | $808.35 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 14 | $741.33 |
| 71045 | Radiologic examination, chest; single view | <1% | 387 | $583.66 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $352.30 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 419 | $346.75 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $319.24 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 380 | $146.90 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 752 | $115.70 |
| 81001 | <1% | 886 | $100.42 | |
| 82077 | <1% | 27 | $89.10 | |
| 83690 | <1% | 382 | $86.16 | |
| 81003 | <1% | 411 | $75.98 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 507 | $75.42 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 15 | $73.02 |
| 80069 | <1% | 13 | $64.85 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 159 | $53.72 |
| 82570 | <1% | 12 | $45.79 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 150 | $44.11 |
| 86140 | <1% | 27 | $41.10 | |
| 81025 | <1% | 367 | $40.14 | |
| 85027 | <1% | 12 | $35.50 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 32 | $35.09 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 427 | $33.10 |
| 85610 | <1% | 57 | $30.10 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 898 | $26.44 |
| 84484 | <1% | 257 | $23.09 | |
| 84156 | <1% | 12 | $22.86 | |
| J3490 | Unclassified drugs | <1% | 1,035 | $21.19 |
| 80306 | <1% | 15 | $17.14 | |
| 82962 | <1% | 118 | $14.32 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 380 | $10.24 |
| 83735 | <1% | 30 | $6.48 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 258 | $1.95 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 80 | $0.00 |
| 87807 | 0% | 43 | $0.00 | |
| 84703 | 0% | 29 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 39 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 37 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 47 | $0.00 |
| 85379 | 0% | 12 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 18 | $0.00 |
| 83605 | 0% | 27 | $0.00 | |
| 87040 | 0% | 17 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 20 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 565 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 44 | $0.00 |
| 87400 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWATERMAN, ANDREW (CEO)
| Provider | Location | Paid |
|---|---|---|
| Grand Island Regional Medical Center | Grand Island, NE | $585K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.